Policy & Regulation
Haisco receives US FDA approval for anaesthetic Cipepofol
...
hVIVO secures Decoy Therapeutics consultancy contract for antiviral development
1 June 2026 - Clinical development partner hVIVO plc (AIM: HVO) announced on Monday that it has signed a consultancy agreement with Decoy Therapeutics to support the development of its respiratory ant...
AstraZeneca reports trial results showing immunotherapy combinations reduce progression risk in liver cancer
1 June 2026 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) on Monday reported positive results from the EMERALD-3 Phase III trial evaluating IMFINZI (durvalumab) in combina...
Rallybio and Avenzo Therapeutics announce merger agreement and USD215m financing
1 June 2026 - Clinical-stage biotechnology companies Rallybio Corporation (Nasdaq:RLYB) and Avenzo Therapeutics Inc announced on Monday that they have entered into a definitive merger agreement under ...
IBA launches Cyclone iKure for industrial-scale Astatine-211 production
1 June 2026 - Particle accelerator technology company Ion Beam Applications S.A. (IBA) (Euronext Brussels:IBAB) announced on Monday the launch of Cyclone iKure, a dedicated cyclotron designed for rout...
Circio and GenAssist announce gene therapy research collaboration for muscle diseases and in vivo cell therapy
1 June 2026 - Biotechnology companie Circio Holding ASA (OSE:CRNA) and GenAssist Ltd announced on Monday that they have entered into a research collaboration to develop circVec-enhanced AAV vectors fo...